$NUMD Schedule 13D: Fred Tejada reports Series X Super Voting Preferred (100M votes) and may share voting power over about 8.13M common (~9.7%) via a July 8 voting agreement tied to an exchange deal.…
NU-MED PLUS INC
Company and security reference data from OTC Markets Group.
DD entries are user-generated due diligence, not investment advice. Moderated. Filings link to sec.gov.
Not yet analyzed. Dilution facts are extracted from new SEC filings on a rolling basis - check back soon.
Figures are AI-extracted from the company's own SEC filings and may contain errors - always verify against the linked filing. This is not investment advice.
